Put patients first in line for life-saving and life-extending medications by improving sales team identification of treating providers. Optimize your sales force with CareSet’s Monthly Medicare HCP Alerts by finding doctors with patients who recently became eligible for your therapy. With more than a decade of experience unlocking Medicare data, CareSet is the only company on the market to offer precisely targeted Monthly Medicare HCP alerts.
CareSet profiles chronic diseases of high prevalence among Medicare populations to identify managing providers and institutions. As new treatments advance from first line to later line, CareSet employs time series analysis to reveal the treatment patterns used by Healthcare Providers (HCPs) and by Healthcare Organizations (HCOs).
"When weeks, even days matter with later lines of therapy, accuracy and timeliness matters. Until CareSet, we didn't realize we had gaps in data, making physician targeting so much more difficult."
– Tom Boulay
Senior Director of Commercial Insights,
Deciphera Pharmaceuticals
Key fields shown below are available from monthly HCP alerts when Medicare patients are diagnosed with a key indication or switch line of therapy.
Even before going to market, CareSet’s Medicare HCP Alerts helps manufacturers gain clarity of ideal HCP profiles. Once in the market, CareSet flags any HCP with patients receiving new diagnoses and/or change in therapies, including before and after initial diagnoses, overlap, fall off, and treatment holiday.
"We are tracking 15% - 20% more opportunities per month to find rare, late line patients that can benefit from our therapy”
Ut pharetra sit amet aliquam id diam maecenas ultricies hendrerit dolor magna eget est lorem ipsum dolor sit amet mauris in aliquam sem fringilla ut morbi tincidunt dis parturient montes nascetur ridiculus.
Ut pharetra sit amet aliquam id diam maecenas ultricies hendrerit dolor magna eget est lorem ipsum dolor sit amet mauris in aliquam sem fringilla ut morbi tincidunt dis parturient montes nascetur ridiculus.